Deep Genomics has a total of 68 patents globally, out of which 18 have been granted. Of these 68 patents, 66% patents are active. The United States of America is where Deep Genomics has filed the maximum number of patents, followed by Europe (EPO) and Canada. Parallelly, the United States of America seems to be the main focused R&D centre while Canada is the origin country of Deep Genomics.
Deep Genomics was founded in 2015. Deep Genomics is a biotechnology company that harnesses artificial intelligence to develop new medicines for genetic disorders. By analyzing complex genetic data, their AI platform identifies potential treatments for conditions that currently lack effective therapies.
Do read about some of the most popular patents of Deep Genomics which have been covered by us in this article and also you can find Deep Genomics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Deep Genomics patent portfolio.
How many patents does Deep Genomics have?
Deep Genomics has a total of 68 patents globally. These patents belong to 14 unique patent families. Out of 68 patents, 45 patents are active.
How Many Patents did Deep Genomics File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Applications Filed | Patents Granted |
| 2024 | 2 | 6 |
| 2023 | – | 6 |
| 2022 | 2 | 2 |
| 2021 | 4 | 2 |
| 2020 | 16 | – |
| 2019 | 19 | 2 |
| 2018 | 7 | – |
| 2017 | 2 | – |
| 2016 | 14 | – |
| 2015 | 2 | – |
How many Deep Genomics patents are Alive/Dead?
Worldwide Patents
How Many Patents did Deep Genomics File in Different Countries?
Countries in which Deep Genomics Filed Patents
| Country | Patents |
| United States of America | 21 |
| Canada | 10 |
| Europe (EPO) | 10 |
| Colombia | 1 |
| Australia | 1 |
| India | 1 |
| Singapore | 1 |
| Israel | 1 |
| Mexico | 1 |
| Chile | 1 |
| China | 1 |
| Brazil | 1 |
| Philippines | 1 |
| Hong Kong | 1 |
| Japan | 1 |
| Germany | 1 |
| South Korea | 1 |
Where are Research Centers of Deep Genomics Patents Located?
Best Deep Genomics Patents
US20180107927A1 is the most popular patent in the Deep Genomics portfolio. It has received 39 citations so far from companies like Illumina, Sanofi Pasteur and HumanCode, Inc.
Below is the list of most cited patents of Deep Genomics:
| Publication Number | Citation Count |
| WO2016145516A1 | 67 |
| WO2016201564A1 | 41 |
| US20180107927A1 | 39 |
| WO2018006152A1 | 25 |
| US10185803B2 | 13 |
| US10410118B2 | 9 |
| WO2017190211A1 | 7 |
| US11322225B2 | 6 |
| CA3107649A1 | 6 |
| WO2020172755A1 | 5 |
What Percentage of Deep Genomics US Patent Applications were Granted?
Deep Genomics (Excluding its subsidiaries) has filed 20 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 12 has been granted leading to a grant rate of 92.31%.
Below are the key stats of Deep Genomics patent prosecution at the USPTO.
Which Law Firms are Managing US Patents for Deep Genomics?
| Law Firm | Total Applications | Success Rate |
| Wilson Sonsini Goodrich & Rosati | 17 | 91.67% |
| Clark+Elbing Llp | 3 | 100.00% |
What Technologies are covered by Deep Genomics?
Deep Genomics is advancing precision medicine with artificial intelligence and machine learning for drug discovery and oligonucleotide-based therapies. Their innovations also target genetic disorders while also exploring ligand-based drug delivery.
What are Deep Genomics key innovation segments?
The chart below distributes patents filed by Deep Genomics in different countries on the basis of the technology protected in patents. It also represents the markets where Deep Genomics thinks it’s important to protect particular technology inventions.
R&D Focus: How has Deep Genomics search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by Deep Genomics?
